Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Principles of Disease Surveillance01:26

Principles of Disease Surveillance

573
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
573
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

8.9K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
8.9K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

924
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
924
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

8.7K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.7K
tRNA Activation02:26

tRNA Activation

23.1K
Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
23.1K
Activation Energy01:26

Activation Energy

87.1K
Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
87.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate Cancer.

Clinical genitourinary cancer·2026
Same author

Fully Wireless and Flexible Valves for Multiplexed and Prolonged Intravesical Liquid Release.

Advanced healthcare materials·2026
Same author

Noninvasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Prospective Multisite Validation and Comparison with MRI.

The Journal of urology·2026
Same author

Editorial Comment.

The Journal of urology·2026
Same author

Editorial Comment.

The Journal of urology·2026
Same author

Blood- and urine-based biomarkers for the detection of clinically significant prostate cancer: a contemporary review.

Current opinion in urology·2025

Related Experiment Video

Updated: Feb 12, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

879

Biomarkers in active surveillance.

Stacy Loeb1,2,3, Jeffrey J Tosoian4

  • 1Department of Urology, New York University, New York, NY, USA.

Translational Andrology and Urology
|March 30, 2018
PubMed
Summary

Active surveillance for prostate cancer needs better tools. This review covers serum, urine, and tissue markers to improve patient selection and monitoring for active surveillance (AS).

Keywords:
Prostate canceractive surveillance (AS)biomarkersmarkers

More Related Videos

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
08:29

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD

Published on: October 10, 2012

16.8K
Standard Operating Procedure for Lyssavirus Surveillance of the Bat Population in Taiwan
07:55

Standard Operating Procedure for Lyssavirus Surveillance of the Bat Population in Taiwan

Published on: August 27, 2019

8.0K

Related Experiment Videos

Last Updated: Feb 12, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

879
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
08:29

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD

Published on: October 10, 2012

16.8K
Standard Operating Procedure for Lyssavirus Surveillance of the Bat Population in Taiwan
07:55

Standard Operating Procedure for Lyssavirus Surveillance of the Bat Population in Taiwan

Published on: August 27, 2019

8.0K

Area of Science:

  • Urology
  • Oncology
  • Biomarker Research

Background:

  • Active surveillance (AS) is increasingly used for favorable-risk prostate cancer.
  • Current clinical staging limitations hinder optimal patient selection for AS.
  • Serial biopsies for monitoring pose risks like infection and are invasive.

Purpose of the Study:

  • To review existing evidence on biomarkers for active surveillance in prostate cancer.
  • To identify markers that can enhance patient selection for AS.
  • To explore markers for improved monitoring protocols in AS.

Main Methods:

  • Literature review of studies on serum, urine, and tissue markers.
  • Analysis of evidence related to biomarker utility in AS selection and monitoring.
  • Synthesis of current research findings on prostate cancer biomarkers.

Main Results:

  • Significant interest exists in developing novel markers for AS.
  • Serum, urine, and tissue markers show potential for improving AS protocols.
  • Further research is needed to validate these markers for clinical application.

Conclusions:

  • Biomarkers are crucial for refining active surveillance strategies in prostate cancer.
  • Improved selection and monitoring via biomarkers can enhance AS efficacy and patient safety.
  • The reviewed markers offer promising avenues for advancing AS management.